Aesthetic Injectables | Market Insights | Asia Pacific (Supplemental) | 2024
Despite the initial negative impact of the COVID-19 pandemic, the Asia Pacific aesthetic injectable market will grow rapidly through 2032. Players in this market will help to support growth through new and differentiated products; the emergence of domestic players with low-cost offerings will also expand the availability of aesthetic injectables and make them more affordable for patients. Demand for aesthetic injectables will also be spurred by the rising awareness and acceptability of these procedures, as well as a growing patient pool, including nontraditional patient groups such as men and younger individuals.
This Medtech 360 Report provides high-level market metrics for aesthetic injectables in the Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2032.
